These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10729246)

  • 1. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile.
    Churchill M; Chadburn A; Bilinski RT; Bertagnolli MM
    J Surg Res; 2000 Apr; 89(2):169-75. PubMed ID: 10729246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
    Perkins S; Verschoyle RD; Hill K; Parveen I; Threadgill MD; Sharma RA; Williams ML; Steward WP; Gescher AJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):535-40. PubMed ID: 12050094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis.
    Weyant MJ; Carothers AM; Mahmoud NN; Bradlow HL; Remotti H; Bilinski RT; Bertagnolli MM
    Cancer Res; 2001 Mar; 61(6):2547-51. PubMed ID: 11289129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
    Watson SA; Smith AM
    Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
    Lee J; Hargest R; Wasan H; Phillips RK
    Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL; Kettunen AS; Rautonen NE
    Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
    Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
    Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
    Koehl GE; Spitzner M; Ousingsawat J; Schreiber R; Geissler EK; Kunzelmann K
    Oncogene; 2010 Mar; 29(10):1553-60. PubMed ID: 19966863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials.
    Tunstall RG; Sharma RA; Perkins S; Sale S; Singh R; Farmer PB; Steward WP; Gescher AJ
    Eur J Cancer; 2006 Feb; 42(3):415-21. PubMed ID: 16387490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer.
    Javid SH; Moran AE; Carothers AM; Redston M; Bertagnolli MM
    Carcinogenesis; 2005 Mar; 26(3):587-95. PubMed ID: 15579483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium.
    Ding S; McEntee MF; Whelan J; Zemel M
    Nutr Cancer; 2007; 58(2):153-61. PubMed ID: 17640161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
    Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
    Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
    Chae WJ; Gibson TF; Zelterman D; Hao L; Henegariu O; Bothwell AL
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5540-4. PubMed ID: 20212110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice.
    Møllersen L; Paulsen JE; Olstørn HB; Knutsen HK; Alexander J
    Carcinogenesis; 2004 Jan; 25(1):149-53. PubMed ID: 14514656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+)mice.
    Chiu CH; McEntee MF; Whelan J
    Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):269-75. PubMed ID: 10883057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.
    Yang WC; Mathew J; Velcich A; Edelmann W; Kucherlapati R; Lipkin M; Yang K; Augenlicht LH
    Cancer Res; 2001 Jan; 61(2):565-9. PubMed ID: 11212250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.
    Erdman SE; Sohn JJ; Rao VP; Nambiar PR; Ge Z; Fox JG; Schauer DB
    Cancer Res; 2005 May; 65(10):3998-4004. PubMed ID: 15899788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.